EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting the Biology of Aging in Cerebrovascular Disease: Inflammation, Metabolism, Senescence, and Regeneration

Daniela Glavan, Thorsten R Doeppner, Mihaela Abuzan, Dirk M Hermann, Bogdan Capitanescu, Denisa Greta Olaru, Aurel Popa-Wagner iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27041880 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Daniela Glavan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Medical Center Göttingen, 37075 Göttingen, Germany. Hauptthemen laut MEDLINE: Aging, Cerebrovascular Disorders, Inflammation, Regeneration. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union Brussel, European Union, under the PNRR Programme “Targeting Macrophages/Monocytes in the Aged Ischemic Brain by Pharmacological, Genetic, and Cell-Based Tools,”, UEFISCDI Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging is the strongest independent risk factor for cerebrovascular diseases, profoundly influencing vascular structure, immune responses, and regenerative capacity of the brain. Traditional therapeutic strategies, largely developed in younger populations, often show reduced efficacy and increased risk in elderly patients, underscoring the need for age-adapted interventions. Advances in the understanding of cerebrovascular aging have revealed key mechanisms such as vascular senescence, chronic low-grade inflammation, blood–brain barrier dysfunction, mitochondrial impairment, and circadian dysregulation as central drivers of disease progression and poor recovery. This narrative review summarizes emerging therapeutic strategies targeting the molecular and cellular hallmarks of aging-related cerebrovascular disease. These include immunomodulatory and anti-inflammatory approaches, senescence-targeted therapies, stem cell and extracellular vesicle-based regenerative strategies, RNA-based interventions, and metabolic and mitochondrial modulation. Particular emphasis is placed on therapies aimed at restoring neurovascular unit integrity and promoting brain repair in the aged microenvironment. Additionally, this review highlights the growing role of chronobiology and precision medicine, integrating biomarkers and multi-omics approaches to tailor treatments for elderly patients. Collectively, these emerging therapies represent a paradigm shift from symptom-oriented management toward mechanism-based and personalized interventions. Addressing age-specific pathophysiology will be critical for improving outcomes in cerebrovascular diseases in the aging population and for translating experimental advances into effective clinical therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingCerebrovascular DisordersInflammationRegenerationCellular SenescenceHumansAnimals

Stichwörter der Autor:innen

ageingcerebrovascular diseasesinflammationmetabolismregeneration

Autor:innen und Institutionen

  • Department of Neurology, University Medical Center Göttingen, 37075 Göttingen, Germany.
  • Clinic of Psychiatry, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Department of Neurology, University of Giessen Medical School, 35392 Giessen, Germany.
  • Experimental Research Center for Normal and Pathological Aging (ARES), University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Chair of Vascular Neurology and Dementia, Department of Neurology, University Hospital Essen, 45147 Essen, Germany.

ORCID-Profile: Aurel Popa-Wagner

Förderung

  • European Union Brussel
  • European Union, under the PNRR Programme “Targeting Macrophages/Monocytes in the Aged Ischemic Brain by Pharmacological, Genetic, and Cell-Based Tools,”
  • UEFISCDI Project

Zitieren

APA

Glavan, D., Doeppner, T. R., Abuzan, M., Hermann, D. M., Capitanescu, B., Olaru, D. G., & Popa-Wagner, A. (2026). Targeting the Biology of Aging in Cerebrovascular Disease: Inflammation, Metabolism, Senescence, and Regeneration. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27041880

Vancouver

Glavan D, Doeppner TR, Abuzan M, Hermann DM, Capitanescu B, Olaru DG, et al. Targeting the Biology of Aging in Cerebrovascular Disease: Inflammation, Metabolism, Senescence, and Regeneration. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27041880

BibTeX
@article{Glavan2026,
  author = {Glavan, Daniela and Doeppner, Thorsten R and Abuzan, Mihaela and Hermann, Dirk M and Capitanescu, Bogdan and Olaru, Denisa Greta and Popa-Wagner, Aurel},
  title = {Targeting the Biology of Aging in Cerebrovascular Disease: Inflammation, Metabolism, Senescence, and Regeneration},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27041880}
}
Kostenlos starten →